MFS Blended Research Mid Cap Eq C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
MFS Blended Research Mid Cap Equity Fund C BMSDX
- NAV / 1-Day Return $16.89 / −0.59 %
- Fund Size $3.4B
- Adjusted Expense Ratio 1.590%
- Net Expense Ratio 1.590%
- Fee Level: Distribution Low
- Share Class Type Level Load
- Morningstar Category Mid-Cap Blend
- Equity Style Box (Funds) Mid Blend
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 51%
Morningstar’s Analysis BMSDX
Will BMSDX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 17.1
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Northern Trust Corp | 1.85 | 60M | Financial Services |
Ameriprise Financial Inc | 1.80 | 58M | Financial Services |
DexCom Inc | 1.75 | 57M | Healthcare |
Humana Inc | 1.72 | 56M | Healthcare |
Aramark | 1.69 | 55M | Industrials |
Valero Energy Corp | 1.68 | 54M | Energy |
Westinghouse Air Brake Technologies Corp | 1.67 | 54M | Industrials |
Okta Inc Class A | 1.66 | 54M | Technology |
Illumina Inc | 1.63 | 53M | Healthcare |
Popular Inc | 1.60 | 52M | Financial Services |